438 related articles for article (PubMed ID: 8630877)
21. Oncogene amplification in urothelial cancers with p53 gene mutation or MDM2 amplification.
Habuchi T; Kinoshita H; Yamada H; Kakehi Y; Ogawa O; Wu WJ; Takahashi R; Sugiyama T; Yoshida O
J Natl Cancer Inst; 1994 Sep; 86(17):1331-5. PubMed ID: 8064891
[TBL] [Abstract][Full Text] [Related]
22. Pathogenetic significance of p53 and c-Ki-ras gene mutations and human papillomavirus DNA integration in adenocarcinoma of the uterine cervix and uterine isthmus.
Jiko K; Tsuda H; Sato S; Hirohashi S
Int J Cancer; 1994 Dec; 59(5):601-6. PubMed ID: 7960232
[TBL] [Abstract][Full Text] [Related]
23. The state of the p53 gene in human papillomavirus (HPV)-positive and HPV-negative genital precancer lesions and carcinomas as determined by single-strand conformation polymorphism analysis and sequencing.
Kurvinen K; Tervahauta A; Syrjänen S; Chang F; Syrjänen K
Anticancer Res; 1994; 14(1A):177-81. PubMed ID: 8166446
[TBL] [Abstract][Full Text] [Related]
24. Role of human papillomavirus and p53 tumor suppressor gene in cervical carcinogenesis.
Kim KH; Kim YS
Yonsei Med J; 1995 Nov; 36(5):412-25. PubMed ID: 8546000
[TBL] [Abstract][Full Text] [Related]
25. Oncogene alterations in carcinomas of the uterine cervix: overexpression of the epidermal growth factor receptor is associated with poor prognosis.
Kersemaekers AM; Fleuren GJ; Kenter GG; Van den Broek LJ; Uljee SM; Hermans J; Van de Vijver MJ
Clin Cancer Res; 1999 Mar; 5(3):577-86. PubMed ID: 10100709
[TBL] [Abstract][Full Text] [Related]
26. Human papillomavirus infection and TP53 gene mutation in primary cervical carcinoma.
Kim JW; Cho YH; Lee CG; Kim JH; Kim HK; Kim EJ; Han KT; Namkoong SE
Acta Oncol; 1997; 36(3):295-300. PubMed ID: 9208900
[TBL] [Abstract][Full Text] [Related]
27. The roles of E6-AP and MDM2 in p53 regulation in human papillomavirus-positive cervical cancer cells.
Traidej M; Chen L; Yu D; Agrawal S; Chen J
Antisense Nucleic Acid Drug Dev; 2000 Feb; 10(1):17-27. PubMed ID: 10726657
[TBL] [Abstract][Full Text] [Related]
28. MDM2 gene amplification and transcript levels in human sarcomas: relationship to TP53 gene status.
Flørenes VA; Maelandsmo GM; Forus A; Andreassen A; Myklebost O; Fodstad O
J Natl Cancer Inst; 1994 Sep; 86(17):1297-302. PubMed ID: 8064888
[TBL] [Abstract][Full Text] [Related]
29. Expression of p53 protein related to the presence of human papillomavirus (HPV) DNA in genital carcinomas and precancer lesions.
Tervahauta AI; Syrjänen SM; Väyrynen M; Saastamoinen J; Syrjänen KJ
Anticancer Res; 1993; 13(4):1107-11. PubMed ID: 8394670
[TBL] [Abstract][Full Text] [Related]
30. Elderly Japanese women with cervical carcinoma show higher proportions of both intermediate-risk human papillomavirus types and p53 mutations.
Nakagawa S; Yoshikawa H; Jimbo H; Onda T; Yasugi T; Matsumoto K; Kino N; Kawana K; Kozuka T; Nakagawa K; Aoki M; Taketani Y
Br J Cancer; 1999 Mar; 79(7-8):1139-44. PubMed ID: 10098748
[TBL] [Abstract][Full Text] [Related]
31. Frequent mutations of p53 gene in oesophageal squamous cell carcinomas with and without human papillomavirus (HPV) involvement suggest the dominant role of environmental carcinogens in oesophageal carcinogenesis.
Chang F; Syrjänen S; Tervahauta A; Kurvinen K; Wang L; Syrjänen K
Br J Cancer; 1994 Aug; 70(2):346-51. PubMed ID: 8054284
[TBL] [Abstract][Full Text] [Related]
32. The status of human papillomavirus and tumor suppressor genes p53 and p16 in carcinomas of uterine cervix from India.
Munirajan AK; Kannan K; Bhuvarahamurthy V; Ishida I; Fujinaga K; Tsuchida N; Shanmugam G
Gynecol Oncol; 1998 Jun; 69(3):205-9. PubMed ID: 9648588
[TBL] [Abstract][Full Text] [Related]
33. Low frequency of p53 mutations in cervical carcinomas among Brazilian women.
Pinheiro NA; Villa LL
Braz J Med Biol Res; 2001 Jun; 34(6):727-33. PubMed ID: 11378660
[TBL] [Abstract][Full Text] [Related]
34. Analysis of the K-ras and p53 pathways in X-ray-induced lung tumors in the rat.
Belinsky SA; Middleton SK; Picksley SM; Hahn FF; Nikula KJ
Radiat Res; 1996 Apr; 145(4):449-56. PubMed ID: 8600505
[TBL] [Abstract][Full Text] [Related]
35. The state of p53 in primary human cervical carcinomas and its effects in human papillomavirus-immortalized human cervical cells.
Chen TM; Chen CA; Hsieh CY; Chang DY; Chen YH; Defendi V
Oncogene; 1993 Jun; 8(6):1511-8. PubMed ID: 8389030
[TBL] [Abstract][Full Text] [Related]
36. "Low-risk" and "high-risk" HPV-infection and K-ras gene point mutations in human cervical cancer: a study of 31 cases.
Stenzel A; Semczuk A; Rózyńskal K; Jakowicki J; Wojcierowski J
Pathol Res Pract; 2001; 197(9):597-603. PubMed ID: 11569923
[TBL] [Abstract][Full Text] [Related]
37. The origin and molecular characterization of adenoid basal carcinoma of the uterine cervix.
Jones MW; Kounelis S; Papadaki H; Bakker A; Swalsky PA; Finkelstein SD
Int J Gynecol Pathol; 1997 Oct; 16(4):301-6. PubMed ID: 9421067
[TBL] [Abstract][Full Text] [Related]
38. Infrequency of MDM2 gene amplification in pediatric solid tumors and lack of association with p53 mutations in adult squamous cell carcinomas.
Waber PG; Chen J; Nisen PD
Cancer Res; 1993 Dec; 53(24):6028-30. PubMed ID: 8261417
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical expression of mdm2 and p21WAF1 in invasive cervical cancer: correlation with p53 protein and high risk HPV infection.
Troncone G; Martinez JC; Palombini L; De Rosa G; Mugica C; Rodriguez JA; Zeppa P; Di Vizio D; Lucariello A; Piris MA
J Clin Pathol; 1998 Oct; 51(10):754-60. PubMed ID: 10023338
[TBL] [Abstract][Full Text] [Related]
40. Expression of p53, MDM2, and p21 proteins in high-grade cervical intraepithelial neoplasia and relationship to human papillomavirus infection.
Lie AK; Skarsvåg S; Skomedal H; Haugen OA; Holm R
Int J Gynecol Pathol; 1999 Jan; 18(1):5-11. PubMed ID: 9891236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
